DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Has $3.86 Million Position in Chemed Co. (NYSE:CHE)

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main decreased its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 48.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,285 shares of the company's stock after selling 6,929 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main's holdings in Chemed were worth $3,860,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new stake in Chemed in the 4th quarter valued at approximately $95,872,000. Freestone Grove Partners LP acquired a new stake in Chemed in the 4th quarter valued at approximately $61,664,000. Raymond James Financial Inc. acquired a new stake in Chemed in the 4th quarter valued at approximately $42,023,000. Citadel Advisors LLC grew its holdings in Chemed by 197.4% in the 4th quarter. Citadel Advisors LLC now owns 77,143 shares of the company's stock valued at $40,870,000 after buying an additional 51,206 shares during the last quarter. Finally, FMR LLC grew its holdings in Chemed by 18.9% in the 4th quarter. FMR LLC now owns 283,790 shares of the company's stock valued at $150,352,000 after buying an additional 45,174 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Trading Up 2.2%

CHE stock traded up $12.48 during midday trading on Friday, hitting $578.61. The stock had a trading volume of 44,122 shares, compared to its average volume of 101,068. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The stock has a 50-day simple moving average of $586.60 and a 200 day simple moving average of $564.22. The firm has a market capitalization of $8.46 billion, a price-to-earnings ratio of 29.21, a P/E/G ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The company had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period last year, the firm earned $5.20 EPS. On average, equities analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Analyst Ratings Changes

CHE has been the topic of a number of research analyst reports. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada raised their target price on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th.

Insiders Place Their Bets

In related news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction on Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total value of $866,790.00. Following the sale, the executive vice president now owns 16,127 shares of the company's stock, valued at $9,319,148.22. The trade was a 8.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,000 shares of company stock worth $3,534,135 over the last quarter. Company insiders own 3.29% of the company's stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.